Navigation Links
£28.5M investment for groundbreaking new research facility
Date:7/24/2008

A groundbreaking new research facility is planned to enable unprecedented understanding of how economic, social and biological factors combine to shape human behaviour. The 28.5 million funding comes from the science portfolio of the Department of Innovation, Universities and Skills (DIUS), and will be used for the study of birth cohorts. The new facility will be a collaboration between the Economic and Social Research Council (ESRC) and the Medical Research Council (MRC).

Birth Cohorts are a set of studies which track a large sample of babies from birth into adulthood, gathering information on their lives as they grow up. These studies have produced a series of important findings which include for example the risks of smoking in pregnancy, childhood asthma and the link with parental occupational exposure to allergens, the origins and consequences of child poverty, and the long-term impacts of education and training. British birth cohort studies are recognised worldwide as unique and remarkable data resources which have underpinned innovative research on the health, wellbeing and socio-economic status of a wide range of people in the UK.

This pioneering facility will, for the first time, enable the co-ordination of data collection across existing birth cohort studies which span over 60 years. The most significant impact of the facility will be its ability to allow analysis across the generations by comparing patterns of activity, at similar ages, amongst the different cohorts' members. For example, it will enable the analysis of the latter 20th century/early 21st century phenomenon of women delaying starting a family what are the social, economic and educational impacts of having older parents compared with earlier generations? As such, it will provide the bedrock for cutting edge research to be undertaken, across the lifecourse, into such important areas as health and poverty.

The new resource will also expand the series by creating a new cohort to extend the series over a further 12 years. The study will follow a group of newborn infants in 2012 and will be designed to investigate how pre-natal influences, as well as the interplay of genetic and environmental factors, affect human development.

Speaking about the announcement, Professor Ian Diamond, Chief Executive of the ESRC, said, "Obviously, this is tremendous news for the ESRC. The research facility will unlock the potential of the world renowned Birth Cohort Studies and will position the UK at the forefront of pioneering research in the areas of public health, education and social integration of individuals and families. Such information is crucial in enabling policymakers to understand the ever more complex nature of 21st century society in Britain."

Sir Leszek Borysiewicz, Chief Executive of the Medical Research Council, said "Birth cohort studies are a vital tool for increasing our understanding of how our environment and development before and after we are born influence our health and predisposition to diseases in later life. We look forward to working with the ESRC in maximising the potential of these important information resources."


'/>"/>

Contact: Kelly Barnett
Kelly.barnett@esrc.ac.uk
01-793-413-032
Economic & Social Research Council
Source:Eurekalert

Related medicine news :

1. £5 million investment in personalized medicines to cut patient deaths
2. Governor Rendell Announces $2.1 Million Investment in Small Transit Vehicles
3. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
4. Experts Agree. Ohios Technology Investment Future Looks Bright
5. Susquehanna Health and Siemens Announce Plans to Improve Hospital Facilities Through Technology Investment
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Blue Cross of California Invests $10.6 Million in Community Clinics Through the Investment in a Healthy California Program
8. MGT Capital Investments Announces New Commercial Partnerships for Subsidiary Company Medicexchange PLC
9. WallSt.net Updates Investment Community Through All-New Interview With Ingen Technologies
10. WallSt.net Updates Investment Community Through All-New Interview With XTend Medical
11. WallSt.net (www.wallst.net) Updates the Investment Community Through All-New Interviews With XMDC, POSS and TYPE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... ... June 24, 2017 , ... Doorknobs are for convenience, deadbolts are ... getting a guard dog or having an alarm system installed. But unless there is ... entry. Yair Frenkel, owner of TX Premier Locksmith in Killeen, TX says: “In the ...
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... By scoring ... its ninth consecutive four-star rating from premier online charity evaluator, Charity Navigator, validating ANRF's ... top 1% of all charities reviewed by Charity Navigator and earns ANRF a spot ...
(Date:6/23/2017)... Va. (PRWEB) , ... June 23, 2017 , ... The ... the president's nominee for deputy secretary of Veterans Affairs, retired Marine Col. Thomas G. ... Veterans Affairs. , Bowman brings an intimacy with the issues and challenges ...
(Date:6/23/2017)... New York, NY (PRWEB) , ... June 23, 2017 , ... ... prefer to watch it while others prefer to read it, and some people don't ... printed versus visual pornography. Here's what they found: , Erotic literature can give readers ...
(Date:6/23/2017)... D.C. (PRWEB) , ... June 23, 2017 , ... ... during cooking is essential, and two new videos highlight the importance of correctly ... Specialist Christine Bruhn, Ph.D., who has done extensive research on consumer food safety ...
Breaking Medicine News(10 mins):
(Date:6/14/2017)... 2017 The Bio Supply Management Alliance (BSMA) ... Fremont and the Biomedical Manufacturing Network to ... California by providing a platform ... fostering workforce development. The primary focus of this alliance ... as well as small and mid-sized biomedical companies. ...
(Date:6/13/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... U.S. Food and Drug Administration (FDA) has notified the Company ... its Zhejiang, China manufacturing facility has ... successful clearance of the Warning Letter related to our ... measure of the progress we have made in our ongoing ...
(Date:6/11/2017)... INDIANAPOLIS , June 10, 2017  Eli Lilly and ... results from three Phase 3 studies of galcanezumab, an ... migraine, including late-breaking data on several key secondary endpoints ... Detailed results from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) ... (AHS) annual scientific meeting in Boston ...
Breaking Medicine Technology: